{"id":172387,"date":"2024-02-29T22:31:12","date_gmt":"2024-02-29T19:31:12","guid":{"rendered":"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/"},"modified":"2024-02-29T22:31:12","modified_gmt":"2024-02-29T19:31:12","slug":"ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs","status":"publish","type":"post","link":"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/","title":{"rendered":"Ironwood informa de resultados positivos de Fase III para el tratamiento del SBS"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/kupitiblog.store\/576r\/wp-content\/uploads\/2024\/02\/8974ac403ebdb1e80fa1046c1a8b07bf.jpg\"  \/> <span class=\"text\"> <\/span> <i class=\"imgGrad\"><\/i>    &nbsp;                <\/p>\n<p>BOSTON &#8212; Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), una empresa del sector sanitario especializada en tratamientos gastrointestinales, ha anunciado hoy los resultados positivos del ensayo de fase III STARS de apraglutida, un tratamiento para pacientes adultos con s\u00edndrome de intestino corto con insuficiencia intestinal (SBS-IF).<\/p>\n<p>El ensayo cumpli\u00f3 su criterio de valoraci\u00f3n primario, mostrando una reducci\u00f3n significativa del volumen semanal de soporte parenteral (PS) en la semana 24 en comparaci\u00f3n con placebo.<\/p>\n<p>En el ensayo global participaron 164 pacientes y se demostr\u00f3 una reducci\u00f3n del 25,5% en el volumen de PS para los tratados con apraglutida frente a una reducci\u00f3n del 12,5% para los que recibieron placebo. Adem\u00e1s, el 43% de los pacientes que recibieron apraglutida lograron al menos un d\u00eda a la semana sin PS en la semana 24, frente al 27,5% del grupo placebo.<\/p>\n<p>Kishore R. Iyer, investigador principal coordinador del ensayo, destac\u00f3 la importancia de estos resultados y se\u00f1al\u00f3 la importancia de reducir la dependencia de la PS en los pacientes con SBS-IF. Aunque no se alcanzaron los objetivos secundarios clave tercero y cuarto del ensayo, apraglutida mostr\u00f3 una tendencia favorable.<\/p>\n<p>El perfil de seguridad de la apraglutida coincidi\u00f3 con el de estudios anteriores, y en general los participantes toleraron bien el f\u00e1rmaco. El Dr. Michael Shetzline, director m\u00e9dico de Ironwood, expres\u00f3 su confianza en el potencial de la apraglutida para mejorar la atenci\u00f3n a los pacientes con SBS dependientes de PS.<\/p>\n<p>Tras estos resultados, Ironwood tiene previsto presentar una solicitud de nuevo f\u00e1rmaco (NDA) y otros documentos reglamentarios para la aprobaci\u00f3n de la apraglutida. Se espera presentar datos adicionales del estudio STARS en congresos m\u00e9dicos a finales de este a\u00f1o.<\/p>\n<p>El SBS-IF es una enfermedad debilitante que afecta a unos 18.000 pacientes adultos en EE.UU., Europa y Jap\u00f3n. Suele conllevar una pesada carga de tratamiento, incluida la necesidad de largas infusiones diarias de PS, lo que repercute en la calidad de vida de los pacientes y supone un riesgo de complicaciones graves.<\/p>\n<p>Ironwood celebrar\u00e1 hoy una conferencia telef\u00f3nica y un webcast para comentar los resultados principales del ensayo STARS. Esta noticia se basa en un comunicado de prensa emitido por Ironwood Pharmaceuticals.<\/p>\n<\/p>\n<p><a target=\"_blank\" rel=\"nofollow noopener\" href=\"http:\/\/es.investing.com\/news\/stock-market-news\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs-93CH-2587682\">Fuente<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; BOSTON &#8212; Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), una empresa del sector sanitario especializada en tratamientos gastrointestinales, ha anunciado hoy los resultados positivos del ensayo de fase III STARS de apraglutida, un tratamiento para pacientes adultos con s\u00edndrome de intestino corto con insuficiencia intestinal (SBS-IF). El ensayo cumpli\u00f3 su criterio de valoraci\u00f3n primario, mostrando una reducci\u00f3n &hellip;<\/p>\n","protected":false},"author":1,"featured_media":172915,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3360],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v16.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ironwood informa de resultados positivos de Fase III para el tratamiento del SBS - BiznesSMI - \u043a\u043e\u0442\u0438\u0440\u043e\u0432\u043a\u0438 \u0432\u0430\u043b\u044e\u0442, \u0430\u043a\u0446\u0438\u0438, \u0444\u043e\u0440\u0435\u043a\u0441, \u0438\u043d\u0434\u0435\u043a\u0441\u044b, \u0430 \u0442\u0430\u043a\u0436\u0435 \u0442\u0435\u0445\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u043d\u0430\u043b\u0438\u0437, \u0433\u0440\u0430\u0444\u0438\u043a\u0438, \u0444\u0438\u043d\u0430\u043d\u0441\u043e\u0432\u044b\u0435 \u043d\u043e\u0432\u043e\u0441\u0442\u0438 \u0438 \u0430\u043d\u0430\u043b\u0438\u0442\u0438\u043a\u0430.<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"ru_RU\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ironwood informa de resultados positivos de Fase III para el tratamiento del SBS - BiznesSMI - \u043a\u043e\u0442\u0438\u0440\u043e\u0432\u043a\u0438 \u0432\u0430\u043b\u044e\u0442, \u0430\u043a\u0446\u0438\u0438, \u0444\u043e\u0440\u0435\u043a\u0441, \u0438\u043d\u0434\u0435\u043a\u0441\u044b, \u0430 \u0442\u0430\u043a\u0436\u0435 \u0442\u0435\u0445\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u043d\u0430\u043b\u0438\u0437, \u0433\u0440\u0430\u0444\u0438\u043a\u0438, \u0444\u0438\u043d\u0430\u043d\u0441\u043e\u0432\u044b\u0435 \u043d\u043e\u0432\u043e\u0441\u0442\u0438 \u0438 \u0430\u043d\u0430\u043b\u0438\u0442\u0438\u043a\u0430.\" \/>\n<meta property=\"og:description\" content=\"&nbsp; BOSTON &#8212; Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), una empresa del sector sanitario especializada en tratamientos gastrointestinales, ha anunciado hoy los resultados positivos del ensayo de fase III STARS de apraglutida, un tratamiento para pacientes adultos con s\u00edndrome de intestino corto con insuficiencia intestinal (SBS-IF). El ensayo cumpli\u00f3 su criterio de valoraci\u00f3n primario, mostrando una reducci\u00f3n &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/\" \/>\n<meta property=\"og:site_name\" content=\"BiznesSMI - \u043a\u043e\u0442\u0438\u0440\u043e\u0432\u043a\u0438 \u0432\u0430\u043b\u044e\u0442, \u0430\u043a\u0446\u0438\u0438, \u0444\u043e\u0440\u0435\u043a\u0441, \u0438\u043d\u0434\u0435\u043a\u0441\u044b, \u0430 \u0442\u0430\u043a\u0436\u0435 \u0442\u0435\u0445\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u043d\u0430\u043b\u0438\u0437, \u0433\u0440\u0430\u0444\u0438\u043a\u0438, \u0444\u0438\u043d\u0430\u043d\u0441\u043e\u0432\u044b\u0435 \u043d\u043e\u0432\u043e\u0441\u0442\u0438 \u0438 \u0430\u043d\u0430\u043b\u0438\u0442\u0438\u043a\u0430.\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-29T19:31:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kupitiblog.store\/576r\/wp-content\/uploads\/2024\/02\/8974ac403ebdb1e80fa1046c1a8b07bf.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u041f\u0440\u0438\u043c\u0435\u0440\u043d\u043e\u0435 \u0432\u0440\u0435\u043c\u044f \u0434\u043b\u044f \u0447\u0442\u0435\u043d\u0438\u044f\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 \u043c\u0438\u043d\u0443\u0442\u044b\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kupitiblog.store\/576r\/#website\",\"url\":\"https:\/\/kupitiblog.store\/576r\/\",\"name\":\"BiznesSMI - \\u043a\\u043e\\u0442\\u0438\\u0440\\u043e\\u0432\\u043a\\u0438 \\u0432\\u0430\\u043b\\u044e\\u0442, \\u0430\\u043a\\u0446\\u0438\\u0438, \\u0444\\u043e\\u0440\\u0435\\u043a\\u0441, \\u0438\\u043d\\u0434\\u0435\\u043a\\u0441\\u044b, \\u0430 \\u0442\\u0430\\u043a\\u0436\\u0435 \\u0442\\u0435\\u0445\\u043d\\u0438\\u0447\\u0435\\u0441\\u043a\\u0438\\u0439 \\u0430\\u043d\\u0430\\u043b\\u0438\\u0437, \\u0433\\u0440\\u0430\\u0444\\u0438\\u043a\\u0438, \\u0444\\u0438\\u043d\\u0430\\u043d\\u0441\\u043e\\u0432\\u044b\\u0435 \\u043d\\u043e\\u0432\\u043e\\u0441\\u0442\\u0438 \\u0438 \\u0430\\u043d\\u0430\\u043b\\u0438\\u0442\\u0438\\u043a\\u0430.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/kupitiblog.store\/576r\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ru-RU\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/#primaryimage\",\"inLanguage\":\"ru-RU\",\"url\":\"https:\/\/kupitiblog.store\/576r\/wp-content\/uploads\/2024\/03\/8974ac403ebdb1e80fa1046c1a8b07bf.jpg\",\"contentUrl\":\"https:\/\/kupitiblog.store\/576r\/wp-content\/uploads\/2024\/03\/8974ac403ebdb1e80fa1046c1a8b07bf.jpg\",\"width\":800,\"height\":533},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/#webpage\",\"url\":\"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/\",\"name\":\"Ironwood informa de resultados positivos de Fase III para el tratamiento del SBS - BiznesSMI - \\u043a\\u043e\\u0442\\u0438\\u0440\\u043e\\u0432\\u043a\\u0438 \\u0432\\u0430\\u043b\\u044e\\u0442, \\u0430\\u043a\\u0446\\u0438\\u0438, \\u0444\\u043e\\u0440\\u0435\\u043a\\u0441, \\u0438\\u043d\\u0434\\u0435\\u043a\\u0441\\u044b, \\u0430 \\u0442\\u0430\\u043a\\u0436\\u0435 \\u0442\\u0435\\u0445\\u043d\\u0438\\u0447\\u0435\\u0441\\u043a\\u0438\\u0439 \\u0430\\u043d\\u0430\\u043b\\u0438\\u0437, \\u0433\\u0440\\u0430\\u0444\\u0438\\u043a\\u0438, \\u0444\\u0438\\u043d\\u0430\\u043d\\u0441\\u043e\\u0432\\u044b\\u0435 \\u043d\\u043e\\u0432\\u043e\\u0441\\u0442\\u0438 \\u0438 \\u0430\\u043d\\u0430\\u043b\\u0438\\u0442\\u0438\\u043a\\u0430.\",\"isPartOf\":{\"@id\":\"https:\/\/kupitiblog.store\/576r\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/#primaryimage\"},\"datePublished\":\"2024-02-29T19:31:12+00:00\",\"dateModified\":\"2024-02-29T19:31:12+00:00\",\"author\":{\"@id\":\"https:\/\/kupitiblog.store\/576r\/#\/schema\/person\/5d8353a37f91122aa6e3893c3f66436a\"},\"breadcrumb\":{\"@id\":\"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/#breadcrumb\"},\"inLanguage\":\"ru-RU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kupitiblog.store\/576r\/ironwood-informa-de-resultados-positivos-de-fase-iii-para-el-tratamiento-del-sbs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\\u0413\\u043b\\u0430\\u0432\\u043d\\u0430\\u044f \\u0441\\u0442\\u0440\\u0430\\u043d\\u0438\\u0446\\u0430\",\"item\":\"https:\/\/kupitiblog.store\/576r\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ironwood informa de resultados positivos de Fase III para el tratamiento del SBS\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/kupitiblog.store\/576r\/#\/schema\/person\/5d8353a37f91122aa6e3893c3f66436a\",\"name\":\"Admin\",\"url\":\"https:\/\/kupitiblog.store\/576r\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/posts\/172387"}],"collection":[{"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/comments?post=172387"}],"version-history":[{"count":0,"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/posts\/172387\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/media\/172915"}],"wp:attachment":[{"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/media?parent=172387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/categories?post=172387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kupitiblog.store\/576r\/wp-json\/wp\/v2\/tags?post=172387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}